[HTML][HTML] Genome sequencing in microfabricated high-density picolitre reactors

…, JR Knight, JR Lanza, JH Leamon, SM Lefkowitz, M Lei… - Nature, 2005 - nature.com
The proliferation of large-scale DNA-sequencing projects in recent years has driven a
search for alternative methods to reduce time and cost. Here we describe a scalable, highly …

The POT1–TPP1 telomere complex is a telomerase processivity factor

…, ER Podell, AJ Zaug, Y Yang, P Baciu, TR Cech, M Lei - Nature, 2007 - nature.com
Telomeres were originally defined as chromosome caps that prevent the natural ends of
linear chromosomes from undergoing deleterious degradation and fusion events. POT1 (…

Mutations in a newly identified GTPase gene cause autosomal dominant hereditary spastic paraplegia

…, T Tukel, M Apak, T Heiman-Patterson, L Ming… - Nature …, 2001 - nature.com
The hereditary spastic paraplegias (HSPs; Strümpell-Lorrain syndrome, MIM number 18260)
are a diverse class of disorders characterized by insidiously progressive lower-extremity …

[PDF][PDF] Neuropathy target esterase gene mutations cause motor neuron disease

…, M Bui, E Mark, D Thomas, D Tokarz, L Ming… - The American Journal of …, 2008 - cell.com
The possibility that organophosphorus (OP) compounds contribute to motor neuron disease
(MND) is supported by association of paraoxonase 1 polymorphisms with amyotrophic …

Structure of human POT1 bound to telomeric single-stranded DNA provides a model for chromosome end-protection

M Lei, ER Podell, TR Cech - Nature structural & molecular biology, 2004 - nature.com
The POT1 (protection of telomeres 1) protein binds the single-stranded overhang at the ends
of chromosomes in diverse eukaryotes. It is essential for chromosome end-protection in the …

[HTML][HTML] Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer

…, P Kocon, J Zhang, L Zhu, M Lei… - … England Journal of …, 2021 - Mass Medical Soc
Background No adjuvant treatment has been established for patients who remain at high
risk for recurrence after neoadjuvant chemoradiotherapy and surgery for esophageal or …

[HTML][HTML] Nivolumab combination therapy in advanced esophageal squamous-cell carcinoma

…, T Makino, I Xynos, X Liu, M Lei… - … England Journal of …, 2022 - Mass Medical Soc
Background First-line chemotherapy for advanced esophageal squamous-cell carcinoma
results in poor outcomes. The monoclonal antibody nivolumab has shown an overall survival …

A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression

…, A Protacio, RA Flynn, RA Gupta, J Wysocka, M Lei… - Nature, 2011 - nature.com
The genome is extensively transcribed into long intergenic noncoding RNAs (lincRNAs),
many of which are implicated in gene silencing 1 , 2 . Potential roles of lincRNAs in gene …

A hierarchy of timescales in protein dynamics is linked to enzyme catalysis

KA Henzler-Wildman, M Lei, V Thai, SJ Kerns… - Nature, 2007 - nature.com
The synergy between structure and dynamics is essential to the function of biological
macromolecules. Thermally driven dynamics on different timescales have been experimentally …

First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma …

…, K Feeney, JM Cleary, V Poulart, D Cullen, M Lei… - The Lancet, 2021 - thelancet.com
Background First-line chemotherapy for advanced or metastatic human epidermal growth
factor receptor 2 (HER2)-negative gastric or gastro-oesophageal junction adenocarcinoma …